RCG
XPH icon

Ruggie Capital Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Ruggie Capital Group’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-260
Closed -$16K – 332
2015
Q2 		$16K Buy
+260
New +$16.2K 0.01% 155

Other funds holding XPH

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
HF
Hoxton Financial Shepherdstown, West Virginia $194M AUM 6.21% 1-Year Est. Return

Ruggie Capital Group's XPH Position: Q3 2015 in Review

Ruggie Capital Group sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2015, closing a stake of 260 shares — an estimated $16K sold.

Ruggie Capital Group first reported a position in XPH in Q2 2015 and held it in 1 quarter. The position peaked at $16K in Q2 2015. 77 funds tracked by Wall St. Rank hold XPH as of Q3 2015.

  • Ruggie Capital Group reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2015 after selling out during the quarter.
  • Ruggie Capital Group sold 260 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2015, an estimated $16K.
  • Ruggie Capital Group first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2015 and held it in 1 quarter.
  • Ruggie Capital Group's State Street SPDR S&P Pharmaceuticals ETF position peaked at $16K in Q2 2015.
  • 77 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2015.

Based on Ruggie Capital Group's 13F filing for Q3 2015, filed 12 Nov 2015.